← All trials
NCT07158814
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 2, 2025
- Primary completion
- Jan 31, 2026
- Completion date
- Apr 30, 2026
- First posted
- Sep 8, 2025
- Last posted
- Oct 29, 2025
- Enrollment
- 524
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Duke UniversityLead sponsor
- Columbia UniversityCollaborator
- Emory UniversityCollaborator
- Duke UniversityOfficial
- Kaiser PermanenteCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
- University of CincinnatiCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.